Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum

Nature Reviews Endocrinology volume 6, pages 589–593 (2010)Cite this article

Subjects

Abstract

The purpose of a diagnostic test is to identify individuals who have a disorder and reassure those who do not. An HbA1c-based diagnosis of diabetes mellitus or prediabetes fails to meet that purpose. Diabetes mellitus is a disorder of glucose, not HbA1c, metabolism. Microvascular complications in diabetes mellitus are driven by chronic hyperglycemia. The correlation of these complications with HbA1c levels is convenient; however, unlike the direct information provided by glucose, HbA1c values reflect glycemic and nonglycemic factors. The latter include modulators of glucose transport across the erythrocyte membrane, intracellular protein glycation and deglycation, erythrocyte turnover, systemic illness and hematological and medical disorders, among others. Genetic rather than glycemic factors explain most of the variance in HbA1c levels. Finally, HbA1c values are misleading as a measure of average blood glucose among persons of African, Asian, Hispanic and other non-European ancestry. Given the numerous pitfalls, the use of HbA1c levels for diagnosing diabetes mellitus or prediabetes is ill-advised.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. [No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977–986 (1993).

  2. [No authors listed] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837–853 (1998).

  3. International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32, 1327–1334 (2009).

  4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl. 1), S62–S69 (2010).

  5. [No authors listed] Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20, 1183–1197 (1997).

  6. Genuth, S. et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160–3167 (2003).

    Article  Google Scholar 

  7. van't Riet, E. et al. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 33, 61–66 (2010).

    Article  CAS  Google Scholar 

  8. Diabetes Research in Children Network (DirecNet) Study Group. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 31, 381–385 (2008).

  9. Hempe, J. M., Gomez, R., McCarter, R. J. Jr & Chalew, S. A. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J. Diabetes Complications 16, 313–320 (2002).

    Article  Google Scholar 

  10. Gould, B. J., Davie, S. J. & Yudkin, J. S. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin. Chim. Acta 260, 49–64 (1997).

    Article  CAS  Google Scholar 

  11. Hudson, P. R., Child, D. F., Jones, H. & Williams, C. P. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann. Clin. Biochem. 36, 451–459 (1999).

    Article  Google Scholar 

  12. Tattersall, R. B., Pyke, D. A., Ranney, H. M. & Bruckheimer, B. S. Hemoglobin components in diabetes mellitus: studies in identical twins. N. Engl. J. Med. 293, 1171–1173 (1975).

    Article  CAS  Google Scholar 

  13. Snieder, H. et al. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50, 2858–2863 (2001).

    Article  CAS  Google Scholar 

  14. Cohen, R. M. et al. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in non-diabetic twins. Diabetes Care 29, 1739–1743 (2006).

    Article  Google Scholar 

  15. Paterson, A. D. et al. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes 59, 539–549 (2010).

    Article  CAS  Google Scholar 

  16. Khera, P. K. et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 57, 2445–2452 (2008).

    Article  CAS  Google Scholar 

  17. National Glycohemoglobin Standardization Program (NGSP). Factors that interfere with GHB (HbA1c) Test Results [online], (2009).

  18. Cohen, R. M. et al. Red cell lifespan heterogeneity in hematologically normal people sufficient to alter the apparent HbA1c. Blood 112, 4284–4291 (2008).

    Article  CAS  Google Scholar 

  19. Pani, L. N. et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 31, 1991–1996 (2008).

    Article  Google Scholar 

  20. Kramer, C. K., Araneta, M. R. & Barrett-Connor, E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 33, 101–103 (2010).

    Article  CAS  Google Scholar 

  21. Cowie, C. C. et al. Prevalence of diabetes and high risk for diabetes using hemoglobin A1c criteria in the U. S. population in 1988–2006. Diabetes Care 33, 562–568 (2010).

    Article  Google Scholar 

  22. Ziemer, D. C. et al. Glucose-independent, black-white differences in hemoglobin A1c levels. Ann. Intern. Med. 152, 770–777 (2010).

    Article  Google Scholar 

  23. Saaddine, J. B. et al. Distribution of HbA1c levels for children and young adults in the U. S. Third National Health and Nutrition Examination Survey. Diabetes Care 25, 1326–1330 (2002).

    Article  Google Scholar 

  24. Herman, W. H. et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 30, 2453–2457 (2007).

    Article  CAS  Google Scholar 

  25. Selvin, E., Zhu, H. & Brancati, F. L. Elevated A1C in adults without a history of diabetes in the U. S. Diabetes Care 32, 828–833 (2009).

    Article  Google Scholar 

  26. Nathan, D. M. et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 31, 1473–1478 (2008).

    Article  CAS  Google Scholar 

  27. Bleyer, A. J. et al. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet. Med. 26, 128–133 (2009).

    Article  CAS  Google Scholar 

  28. Herman, W. H. et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 94, 1689–1694 (2009).

    Article  CAS  Google Scholar 

  29. Cohen, R. M., Holmes, Y. R., Chenier, T. C. & Joiner, C. H. Discordance between hemoglobin A1c and fructosamine: evidence for a glycosylation gap and its relation to nephropathy in longstanding type 1 diabetes. Diabetes Care 26, 163–167 (2003).

    Article  CAS  Google Scholar 

  30. Christensen, D. L. et al. Moving to an HbA1c based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 33, 580–582 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

S. Dagogo-Jack is supported in part by NIH grants R01 DK067269 and MO1 RR00211.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes & Metabolism, University of Tennessee Health Science Center, 920 Madison Avenue, Suite 300A, Memphis, 38163, TN, USA

    Samuel Dagogo-Jack

Authors
  1. Samuel Dagogo-Jack
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dagogo-Jack, S. Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol 6, 589–593 (2010). https://doi.org/10.1038/nrendo.2010.126

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.126

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing